About ViCardia Therapeutics
ViCardia Therapeutics is a private company based in San Francisco, California. It has reported $700,000 raised in one offering on Form D since May 2026. Its chief executive is Michael Kokesh.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 19, 2026 | May 21, 2026 | $700,000fully sold | 1 | $700K | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on ViCardia Therapeutics's Form D filed May 21, 2026.
MK